PATENT CLAIM ANALYSIS

Application Number: 15752845
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["435", "325000"]

Abstract:
The present invention relates to compositions and methods for disrupting cancer stromal cell networks using synthetic nanoparticles coated with plasma membranes.

Claim (Index 3):
The composition of  claim 1 , wherein the plasma membrane-associated component is retained in a native conformation within the plasma membrane on the surface of the nanoparticle.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15545937', '14449590', '15699796', '14233215', '14726770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6329494372518623
- 35 USC 102 Novelty (BERT): 0.5030582105264366
- Combined Prediction Score: 0.6199603145793198
- Mean Citation Score: 245.999092
- Max Citation Score: 259.45413
- Similarity Product: 181.3738708593464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test